|
Orthologous residues
|
|
Akt1 (human): T308‑p, Akt1 (mouse): T308‑p, Akt1 (rat): T308‑p, Akt1 (fruit fly): T423‑p, Akt1 (cow): T308‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
phospho-antibody, western blotting
|
|
Disease tissue studied:
colorectal cancer, colorectal carcinoma
|
|
Relevant cell lines - cell types - tissues:
T84 (intestinal)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
IFN-gamma
|
|
|
|
increase
|
5 hr
|
|
TNF
|
|
|
|
increase
|
|
|
TNF
|
IFN-gamma
|
|
|
augment treatment-induced increase
|
|
|
IFN-gamma
|
|
|
|
increase
|
72 hr
|
|
TNF
|
|
|
|
increase
|
slight increase
|
|
TNF
|
IFN-gamma
|
|
|
no effect upon treatment-induced increase
|
|
|
|
Downstream Regulation
|
|
Effect of modification (process):
cell growth, altered
|